Does CABOZANTINIB S-MALATE Cause Interstitial lung disease? 186 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 186 reports of Interstitial lung disease have been filed in association with CABOZANTINIB S-MALATE (CABOMETYX). This represents 0.5% of all adverse event reports for CABOZANTINIB S-MALATE.
186
Reports of Interstitial lung disease with CABOZANTINIB S-MALATE
0.5%
of all CABOZANTINIB S-MALATE reports
42
Deaths
79
Hospitalizations
How Dangerous Is Interstitial lung disease From CABOZANTINIB S-MALATE?
Of the 186 reports, 42 (22.6%) resulted in death, 79 (42.5%) required hospitalization, and 15 (8.1%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CABOZANTINIB S-MALATE. However, 186 reports have been filed with the FAERS database.
What Other Side Effects Does CABOZANTINIB S-MALATE Cause?
Diarrhoea (8,282)
Fatigue (6,819)
Off label use (5,245)
Nausea (4,341)
Decreased appetite (4,076)
Blood pressure increased (2,939)
Malignant neoplasm progression (2,718)
Palmar-plantar erythrodysaesthesia syndrome (2,706)
Weight decreased (2,657)
Stomatitis (2,560)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which CABOZANTINIB S-MALATE Alternatives Have Lower Interstitial lung disease Risk?
CABOZANTINIB S-MALATE vs CAFFEINE
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL-MKNL
CABOZANTINIB S-MALATE vs CALCIFEDIOL
CABOZANTINIB S-MALATE vs CALCIPOTRIENE